UBS downgrades Carlyle Group to Neutral from Buy, lowers price target to $47 from $60

UBS downgraded Carlyle Group to Neutral from Buy, reducing its price target to $47 from $60, a 21.7% decrease. Recent analyst price targets for the company range from $42 to $62.

Original reporting
Published Nov 10, 2026, 1:51 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 10, 2026, 1:59 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
UBS downgrades Carlyle Group to Neutral from Buy, lowers price target to $47 from $60 — source image
Decision brief

The 30-second read

$CGBearishHigh
01

Why it matters

The downgrade signals reduced confidence in near‑term earnings or valuation, likely prompting short‑term sellers.

02

Market read

A fresh UBS downgrade with a sizable target cut is a material catalyst for CG, offering traders a clear short‑term action.

03

What to watch

Potential upcoming fund flows or strategic initiatives at Carlyle that could offset the short‑term price pressure.

Relevance 7/10Novelty 7/10Timing: today

Background

Carlyle Group is a publicly traded global investment firm. Analyst actions can move its stock price, especially when accompanied by a significant price‑target revision.

Company-level read

Ticker impact

$CGBearishHigh confidence
Context

UBS downgraded Carlyle Group to Neutral and cut its price target to $47 from $60.

Expected impact

likely downward pressure as the market prices in the target cut

Evidence & confidence

Analyst downgrade with a 21.7% target reduction is a fresh catalyst that typically triggers sell‑side activity.

Market effects

The downgrade may weigh on other private‑equity and alternative‑asset managers as analysts reassess valuation multiples.

Limited to U.S. markets where CG trades; no broader regional effect.

Minimal global impact beyond investors tracking private‑equity stocks.

Counterpoint

If the downgrade reflects a temporary market overreaction, the lower target could present a buying opportunity for long‑term investors.

Key entities

  • UBS

    Investment bank providing the downgrade and new price target.

  • Carlyle Group

    Subject of the downgrade; ticker CG.

Related articles

$CGHigh

Why is Carlyle stock sliding today?

Carlyle Group (CG) stock fell 0.8% to $41.99 in pre-market trading after UBS downgraded it to Neutral, cutting its price target to $47 from $60. UBS cited reduced confidence in Carlyle's growth trajectory and ability to meet 2028 financial targets. Other analysts have also lowered price targets. The stock is below its 52-week high of $67.30 but above its low of $35.41.

$CGHigh

UBS downgrades Carlyle Group stock rating on growth concerns

UBS downgraded Carlyle Group (CG) from Buy to Neutral, lowering its price target to $47. Analysts cited concerns about growth and reduced fee-related earnings forecasts. The stock is down 26.9% year-to-date, trading at $42.31. UBS also lowered its 2027 and 2028 earnings estimates. Carlyle's Q3 2026 results beat expectations but the stock declined due to growth outlook uncertainties.

$CGMed

Carlyle Group Targets First Buyout Fund Close as $200 Billion Fundraising Push Takes Shape

Carlyle Group (CG) aims to close its first buyout fund as part of a $200 billion fundraising initiative. The company announced its first defense fund deal, Secturion, and highlighted a $5 billion structured transaction via AlpInvest. Carlyle expects growth in credit secondaries and fee-related earnings, with a focus on private equity products. The firm is also restructuring its European buyout team, with the next fund expected to be smaller than its predecessor.

$CGMed

Carlyle and EBRD Agree Sale

Carlyle (CG) and EBRD agreed to sell Black Sea Oil & Gas (BSOG), Romania's largest offshore gas producer, to Mazarine Energy. The deal, pending approval, transfers ownership of BSOG, which supplies 12% of Romania's gas demand, to Mazarine. Carlyle invested over $400M in BSOG's Midia Gas Development project. BSOG will remain the operator, ensuring continuity.

$CGHighAI 8/10

Carlyle 3Q 2026: Revenue $334.1M, EPS ($0.02) — 10-Q Summary

Carlyle reported Q3 2026 revenue of $334.1M, a slight YoY decrease, and a net loss of $0.02 per share. Fund management fees and performance allocations declined, while principal investment income and compensation expenses fell. Distributable earnings rose to $432.5M, with $11.0B deployed and $10.8B in inflows. AUM totaled $478.5B.